STAAR SurgicalSTAA
About: Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
Employees: 1,211
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
1% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 75
1.37% less ownership
Funds ownership: 99.54% [Q3] → 98.17% (-1.37%) [Q4]
10% less funds holding
Funds holding: 233 [Q3] → 210 (-23) [Q4]
35% less capital invested
Capital invested by funds: $1.82B [Q3] → $1.18B (-$643M) [Q4]
40% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 48
42% less call options, than puts
Call options by funds: $2.4M | Put options by funds: $4.12M
50% less funds holding in top 10
Funds holding in top 10: 6 [Q3] → 3 (-3) [Q4]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Wells Fargo | 0%upside $17 | Equal-Weight Initiated | 21 Apr 2025 |
Stephens & Co. Mason Carrico 12% 1-year accuracy 3 / 26 met price target | 0%upside $17 | Equal-Weight Reiterated | 18 Mar 2025 |
Canaccord Genuity Jon Young 29% 1-year accuracy 2 / 7 met price target | 0%upside $17 | Hold Maintained | 13 Feb 2025 |
Stifel Thomas Stephan 31% 1-year accuracy 4 / 13 met price target | 18%upside $20 | Buy Maintained | 12 Feb 2025 |
Piper Sandler Matt O'Brien 32% 1-year accuracy 16 / 50 met price target | 6%downside $16 | Neutral Maintained | 12 Feb 2025 |
Financial journalist opinion









